FTO and osteoporosis: A study involving 80 women with varying BMD analysed differences in the expression levels of the major m6A regulators, leading to the identification of four potential biomarkers for osteoporosis diagnosis: METTL16, CBLL1, YTHDF2 and FTO [199].